Adverse-event reports (MAUDE)
Read this first: MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line shows reporting volume for the average device in the same FDA product code — a reporting baseline, not a risk measure.
No adverse-event reports are linked to this device.
Recall history
| Initiated | Recall # | Class | Status | Reason | Quantity | Link basis |
|---|---|---|---|---|---|---|
| 2023-02-01 | Z-1227-2023 | Class II | Open, Classified | New warnings and precautionary statements on product labelling: Reagent 2 (R2) of BIOPHEN Protein C 5 contains the chemical substance - Cesium Chloride which changed classification and has become hazardous according to the CLP regulation ((EC) No 1272/2008) is suspected of damaging fertilityDistribution: US Nationwide distribution in the state of NC. | 2 units | clearance family |
Regulatory clearances
None linked.
Manufacturer compliance record
| Date | Type | Outcome | Facility | Citations |
|---|---|---|---|---|
| 2014-02-13 | OAI | Official action indicated | Hyphen BioMed sasu | 0 |
| 2012-09-05 | WL | Warning Letter | Hyphen BioMed sasu | — |
| 2012-06-20 | OAI | Official action indicated | Hyphen BioMed sasu | 5 |
Similar devices
- ACTICLOT C KIT Biomedica ADI Inc.
- ACTICLOT PROTEIN S Biomedica ADI Inc.
- Asserachrom® Free Protein S DIAGNOSTICA STAGO
- Asserachrom® IX:Ag DIAGNOSTICA STAGO
- Asserachrom® Total Protein S DIAGNOSTICA STAGO
- Asserachrom® VWF:Ag DIAGNOSTICA STAGO
- Asserachrom® tPA DIAGNOSTICA STAGO
- BC von Willebrand Reagent Siemens Healthcare Diagnostics Products GmbH
- BC von Willebrand Reagent Siemens Healthcare Diagnostics Products GmbH
- Berichrom Protein C Siemens Healthcare Diagnostics Products GmbH
- Berichrom Protein C Siemens Healthcare Diagnostics Products GmbH
- Berichrom a2-Antiplasmin Siemens Healthcare Diagnostics Products GmbH
Select up to two to place side-by-side with this device.